AIG
JUNO

American International Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

American International Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,435
Closed -$66K – 3046
2017
Q4 		$66K Buy
+1,435
New +$71.6K ﹤0.01% 2887
2017
Q3 		– Sell
-1,377
Closed -$41K – 3053
2017
Q2 		$41K Sell
1,377
-74
-5% -$1.83K ﹤0.01% 3021
2017
Q1 		$32K Sell
1,451
-68
-4% -$1.46K ﹤0.01% 2913
2016
Q4 		$29K Sell
1,519
-9
-0.6% -$220 ﹤0.01% 2943
2016
Q3 		$45.9K Sell
1,528
-74
-5% -$2.3K ﹤0.01% 2914
2016
Q2 		$61.6K Sell
1,602
-1,029
-39% -$42.7K ﹤0.01% 2889
2016
Q1 		$100K Sell
2,631
-2,395
-48% -$83.5K ﹤0.01% 3431
2015
Q4 		$221K Sell
5,026
-22,612
-82% -$1.12M ﹤0.01% 2744
2015
Q3 		$1.13M Buy
27,638
+20,830
+306% +$914K ﹤0.01% 1374
2015
Q2 		$363K Buy
6,808
+3,050
+81% +$162K ﹤0.01% 2471
2015
Q1 		$228K Sell
3,758
-587
-14% -$28.5K ﹤0.01% 2837
2014
Q4 		$227K Buy
+4,345
New +$194K ﹤0.01% 2835

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

American International Group's JUNO Position: Q1 2018 in Review

American International Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,435 shares — an estimated $66K sold.

American International Group first reported a position in JUNO in Q4 2014 and held it in 12 quarters. The position peaked at $1.13M in Q3 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • American International Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • American International Group sold 1,435 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $66K.
  • American International Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
  • American International Group's Juno Therapeutics, Inc. position peaked at $1.13M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on American International Group's 13F filing for Q1 2018, filed 7 May 2018.